New UMass Chan Medical School research reveals how a gene-silencing therapy targeting age-related macular degeneration could pause visual decline: direc.to/oKRA

#ophthalmology #MacularDegeneration #DryAMD #WetAMD #siRNA #GeneTherapy @rti-umasschan.bsky.social @moltherapy.bsky.social

Safe CNV removal is essential for the success of hESC-RPE transplantation in #wetAMD. The procedure is well-tolerated, and postoperative #fundus inflammation can be managed effectively. ow.ly/MfbR50V8uRx

@isscr.org @cellpress.bsky.social @gairdnerawards.bsky.social @sickkidsvs.bsky.social

Wet #maculardegeneration sucks. Everything is either too dim or too bright. Some colors are off (blue=aqua, purple=brown). Hard to read some text. And computer use is hard. I think being neurodivergent makes accepting it tougher. Everything is wrong, weird, off.
#lowvision
#AMD
#wetAMD

💊The FDA has approved #LYTENAVA (#bevacizumab-vikg) for the treatment of neovascular age-related macular degeneration (#wetAMD).

👁️What is wet #AMD?Wet AMD is a leading cause of vision loss in older adults
🔸Driven by abnormal blood vessel growth and leakage in the retina, largely mediated by #VEGF

Opthea has concluded the final week 52 patient visits in the pivotal Phase 3 COAST trial investigating the superiority and safety of sozinibercept in combination with aflibercept for patients with #WetAMD.

🔗 www.hcplive.com/view...

#Pipeline #Ophthalmology

The FDA (@fda.gov) has approved Lytenava™ (bevacizumab-vikg) for the treatment of neovascular age-related macular degeneration (wet AMD).

Learn more: https://bit.ly/4qYjzbT

#WetAMD #RetinaResearch #Optometry

#$OCUL
Ocular Therapeutix gained 7.5% after #$EYPT’s DURAVYU missed its primary endpoint in the pivotal LUGANO wet AMD study. The development reshapes the long-acting retinal-therapy landscape as Ocular advances AXPAXLI in Phase 3. #OCUL #WetAMD #Biotech
prismmarketview.com/ocular-thera...

REGENXBIO's Sura-Vec Data Put Retinal Gene Therapy Back on the Catalyst Calendar REGENXBIO announced long-term sura-vec data at ASRS, including five-year wet AMD...

https://www.narrowit.com/news/regenxbio-sura-vec-retinal-data-2026-07-18
#REGENXBIO #GeneTherapy #WetAmd #DiabeticRetinopathy

#OutlookTherapeutics #NICERecommendation #Lytenava #bevacizumabgamma #bevacizumab #WetAMD #ophthalmology #biopharmaceuticals #retinadisease #NICE #NICErecommended #VEGF #WetAMDpatients #NHSEngland #NHSWales #MHRA #NORSEONE #NORSETWO #NORSETHREE #clinicaltrials #Cencora
eyewire.news/news/outlook...

Shares in #OutlookTherapeutics lost more than half their value after the #FDA turned down the company's marketing application for its new formulation of bevacizumab gamma as a treatment for wet age-related macular degeneration (#wetAMD).

4DMT puts everything on the line for its bicistronic approach delivering aflibercept and siRNA against VEGF-C. Does this include pausing its 4D-175 asset delivering shortened FH in GA? #wetAMD #CNV #aflibercept #AAV

EU okays extended treatment interval for Bayer, Regeneron's higher-dose Eylea buff.ly/4Yn1bT6

This will move the goalposts for assets whose USP is less frequent dosing. How much better are they going to have to be now? Once a year? #wetAMD #antiVEGF #eylea

Some good news for people with
#DiabeticRetinopathy or #WetAMD
(Wet Age Related Macular Degeneration)!

#VisionHealth

neurosciencenews.com/cancer-drug-...

The lady in the wetamd commercial is profoundly creepy and I cannot explain why